OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Consensus classification of posterior cortical atrophy
Sebastian J. Crutch, Jonathan M. Schott, Gil D. Rabinovici, et al.
Alzheimer s & Dementia (2017) Vol. 13, Iss. 8, pp. 870-884
Open Access | Times Cited: 538
Sebastian J. Crutch, Jonathan M. Schott, Gil D. Rabinovici, et al.
Alzheimer s & Dementia (2017) Vol. 13, Iss. 8, pp. 870-884
Open Access | Times Cited: 538
Showing 1-25 of 538 citing articles:
Alzheimer disease
David S. Knopman, Hélène Amieva, Ronald C. Petersen, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 1528
David S. Knopman, Hélène Amieva, Ronald C. Petersen, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 1528
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
Bruno Dubois, Nicolas Villain, Giovanni B. Frisoni, et al.
The Lancet Neurology (2021) Vol. 20, Iss. 6, pp. 484-496
Open Access | Times Cited: 701
Bruno Dubois, Nicolas Villain, Giovanni B. Frisoni, et al.
The Lancet Neurology (2021) Vol. 20, Iss. 6, pp. 484-496
Open Access | Times Cited: 701
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Gill Livingston, Jonathan Huntley, Kathy Liu, et al.
The Lancet (2024) Vol. 404, Iss. 10452, pp. 572-628
Closed Access | Times Cited: 619
Gill Livingston, Jonathan Huntley, Kathy Liu, et al.
The Lancet (2024) Vol. 404, Iss. 10452, pp. 572-628
Closed Access | Times Cited: 619
Four distinct trajectories of tau deposition identified in Alzheimer’s disease
Jacob W. Vogel, Alexandra L. Young, Neil P. Oxtoby, et al.
Nature Medicine (2021) Vol. 27, Iss. 5, pp. 871-881
Open Access | Times Cited: 551
Jacob W. Vogel, Alexandra L. Young, Neil P. Oxtoby, et al.
Nature Medicine (2021) Vol. 27, Iss. 5, pp. 871-881
Open Access | Times Cited: 551
Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET
Renaud La Joie, Adrienne Visani, Suzanne L. Baker, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 524
Open Access | Times Cited: 475
Renaud La Joie, Adrienne Visani, Suzanne L. Baker, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 524
Open Access | Times Cited: 475
New insights into atypical Alzheimer's disease in the era of biomarkers
Jonathan Graff‐Radford, Keir Yong, Liana G. Apostolova, et al.
The Lancet Neurology (2021) Vol. 20, Iss. 3, pp. 222-234
Open Access | Times Cited: 427
Jonathan Graff‐Radford, Keir Yong, Liana G. Apostolova, et al.
The Lancet Neurology (2021) Vol. 20, Iss. 3, pp. 222-234
Open Access | Times Cited: 427
Longitudinal tau accumulation and atrophy in aging and alzheimer disease
Theresa M. Harrison, Renaud La Joie, Anne Maaß, et al.
Annals of Neurology (2018) Vol. 85, Iss. 2, pp. 229-240
Open Access | Times Cited: 241
Theresa M. Harrison, Renaud La Joie, Anne Maaß, et al.
Annals of Neurology (2018) Vol. 85, Iss. 2, pp. 229-240
Open Access | Times Cited: 241
The complexity of Alzheimer’s disease: an evolving puzzle
Camilla Ferrari, Sandro Sorbi
Physiological Reviews (2021) Vol. 101, Iss. 3, pp. 1047-1081
Closed Access | Times Cited: 208
Camilla Ferrari, Sandro Sorbi
Physiological Reviews (2021) Vol. 101, Iss. 3, pp. 1047-1081
Closed Access | Times Cited: 208
Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer’s disease
Jay Rasmussen, Jasmin Mahler, Natalie Beschörner, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 49, pp. 13018-13023
Open Access | Times Cited: 202
Jay Rasmussen, Jasmin Mahler, Natalie Beschörner, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 49, pp. 13018-13023
Open Access | Times Cited: 202
Early diagnosis of Alzheimer’s disease: the role of biomarkers including advanced EEG signal analysis. Report from the IFCN-sponsored panel of experts
Paolo Maria Rossini, Riccardo Di Iorio, Fabrizio Vecchio, et al.
Clinical Neurophysiology (2020) Vol. 131, Iss. 6, pp. 1287-1310
Open Access | Times Cited: 181
Paolo Maria Rossini, Riccardo Di Iorio, Fabrizio Vecchio, et al.
Clinical Neurophysiology (2020) Vol. 131, Iss. 6, pp. 1287-1310
Open Access | Times Cited: 181
Comorbid neuropathological diagnoses in early versus late-onset Alzheimer’s disease
Salvatore Spina, Renaud La Joie, Cathrine Petersen, et al.
Brain (2021) Vol. 144, Iss. 7, pp. 2186-2198
Open Access | Times Cited: 176
Salvatore Spina, Renaud La Joie, Cathrine Petersen, et al.
Brain (2021) Vol. 144, Iss. 7, pp. 2186-2198
Open Access | Times Cited: 176
Biomarker modeling of Alzheimer’s disease using PET-based Braak staging
Joseph Therriault, Tharick A. Pascoal, Firoza Z Lussier, et al.
Nature Aging (2022) Vol. 2, Iss. 6, pp. 526-535
Open Access | Times Cited: 170
Joseph Therriault, Tharick A. Pascoal, Firoza Z Lussier, et al.
Nature Aging (2022) Vol. 2, Iss. 6, pp. 526-535
Open Access | Times Cited: 170
Imaging biomarkers in neurodegeneration: current and future practices
Peter Young, Mar Estarellas, Emma M. Coomans, et al.
Alzheimer s Research & Therapy (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 165
Peter Young, Mar Estarellas, Emma M. Coomans, et al.
Alzheimer s Research & Therapy (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 165
Dissecting the clinical heterogeneity of early-onset Alzheimer’s disease
Daniel W. Sirkis, Luke W. Bonham, Taylor P. Johnson, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 6, pp. 2674-2688
Open Access | Times Cited: 92
Daniel W. Sirkis, Luke W. Bonham, Taylor P. Johnson, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 6, pp. 2674-2688
Open Access | Times Cited: 92
Biomarkers in Alzheimer’s disease: role in early and differential diagnosis and recognition of atypical variants
Bruno Dubois, Christine A. F. Von Arnim, Nerida Burnie, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 91
Bruno Dubois, Christine A. F. Von Arnim, Nerida Burnie, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 91
European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders
Giovanni B. Frisoni, Cristina Festari, Federico Massa, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 3, pp. 302-312
Open Access | Times Cited: 57
Giovanni B. Frisoni, Cristina Festari, Federico Massa, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 3, pp. 302-312
Open Access | Times Cited: 57
Investigating alpha‐synuclein co‐pathology in Alzheimer's disease by means of cerebrospinal fluid alpha‐synuclein seed amplification assay
G. Bellomo, Andrea Toja, Federico Paolini Paoletti, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 4, pp. 2444-2452
Open Access | Times Cited: 35
G. Bellomo, Andrea Toja, Federico Paolini Paoletti, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 4, pp. 2444-2452
Open Access | Times Cited: 35
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis
Marianne Chapleau, Renaud La Joie, Keir Yong, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 2, pp. 168-177
Open Access | Times Cited: 29
Marianne Chapleau, Renaud La Joie, Keir Yong, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 2, pp. 168-177
Open Access | Times Cited: 29
Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
Gil D. Rabinovici, D. S. Knopman, Javier Arbizu, et al.
Alzheimer s & Dementia (2025)
Open Access | Times Cited: 12
Gil D. Rabinovici, D. S. Knopman, Javier Arbizu, et al.
Alzheimer s & Dementia (2025)
Open Access | Times Cited: 12
Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
Gil D. Rabinovici, D. S. Knopman, Javier Arbizu, et al.
Journal of Nuclear Medicine (2025), pp. jnumed.124.268756-jnumed.124.268756
Closed Access | Times Cited: 2
Gil D. Rabinovici, D. S. Knopman, Javier Arbizu, et al.
Journal of Nuclear Medicine (2025), pp. jnumed.124.268756-jnumed.124.268756
Closed Access | Times Cited: 2
Donanemab: Appropriate use recommendations
G D Rabinovici, D. J. Selkoe, Suzanne E. Schindler, et al.
The Journal of Prevention of Alzheimer s Disease (2025), pp. 100150-100150
Open Access | Times Cited: 2
G D Rabinovici, D. J. Selkoe, Suzanne E. Schindler, et al.
The Journal of Prevention of Alzheimer s Disease (2025), pp. 100150-100150
Open Access | Times Cited: 2
Retinal changes in Alzheimer's disease— integrated prospects of imaging, functional and molecular advances
Veer Bala Gupta, Nitin Chitranshi, Jurre den Haan, et al.
Progress in Retinal and Eye Research (2020) Vol. 82, pp. 100899-100899
Open Access | Times Cited: 116
Veer Bala Gupta, Nitin Chitranshi, Jurre den Haan, et al.
Progress in Retinal and Eye Research (2020) Vol. 82, pp. 100899-100899
Open Access | Times Cited: 116
Progressive dysexecutive syndrome due to Alzheimer’s disease: a description of 55 cases and comparison to other phenotypes
Ryan Townley, Jonathan Graff‐Radford, William G. Mantyh, et al.
Brain Communications (2020) Vol. 2, Iss. 1
Open Access | Times Cited: 110
Ryan Townley, Jonathan Graff‐Radford, William G. Mantyh, et al.
Brain Communications (2020) Vol. 2, Iss. 1
Open Access | Times Cited: 110
Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease
Jennifer L. Whitwell, Jonathan Graff‐Radford, Nirubol Tosakulwong, et al.
Alzheimer s & Dementia (2018) Vol. 14, Iss. 8, pp. 1005-1014
Open Access | Times Cited: 102
Jennifer L. Whitwell, Jonathan Graff‐Radford, Nirubol Tosakulwong, et al.
Alzheimer s & Dementia (2018) Vol. 14, Iss. 8, pp. 1005-1014
Open Access | Times Cited: 102
Alzheimer's Disease Including Focal Presentations
Nicolas Villain, Bruno Dubois
Seminars in Neurology (2019) Vol. 39, Iss. 02, pp. 213-226
Open Access | Times Cited: 100
Nicolas Villain, Bruno Dubois
Seminars in Neurology (2019) Vol. 39, Iss. 02, pp. 213-226
Open Access | Times Cited: 100
